Sign in Create account

Epigral Limited

Chemicals · Chemicals & Petrochemicals

NSE: EPIGRAL BSE: 543332
₹1012.50
▼ -5.60 (-0.55%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
70/100
Moderate
Valuation
78/100
Undervalued
Momentum
26/100
Bearish

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹4,368 Cr
PE (TTM)
16.1
Industry median 24.4 (189 companies)
Price to Book
2.0
PEG (TTM)
-0.4
Institutions holding %
6.59%
FII + DII, latest filed period
Piotroski Score
5
Relative return vs Nifty50, qtr %
2.6
Relative return vs Sector, qtr %
-2.6
Free Cash Flow
₹41 Cr
as of March 31, 2026
Industry median ₹-0 Cr (238 companies)
EPS Growth (YoY)
-38.17%
as of June 30, 2026
Industry median 39.08% (220 companies)
Net Profit Growth (TTM)
-23.81%
as of June 30, 2026
Industry median 13.45% (212 companies)
Operating Revenue Growth (TTM)
4.81%
as of June 30, 2026
Industry median 7.93% (209 companies)
Profit Growth (YoY)
-5.41%
as of March 31, 2026
Industry median 23.11% (213 companies)
Revenue Growth (YoY)
16.29%
as of June 30, 2026
Industry median 17.49% (205 companies)
Current Ratio
1.16
as of March 31, 2026
Industry median 1.87 (237 companies)
Debt to Equity
0.25
as of March 31, 2026
Industry median 0.16 (224 companies)
Interest Coverage
7.60
as of June 30, 2026
Industry median 8.97 (221 companies)
Net Margin
14.06%
as of June 30, 2026
Industry median 7.49% (212 companies)
Operating Margin (EBIT)
19.90%
as of June 30, 2026
Industry median 11.88% (214 companies)
Operating Margin (TTM)
16.15%
as of June 30, 2026
Industry median 9.75% (219 companies)
Return on Assets
9.47%
as of March 31, 2026
Industry median 4.33% (217 companies)
Return on Capital Employed
14.80%
as of March 31, 2026
Industry median 10.34% (218 companies)
Return on Equity
14.94%
as of March 31, 2026
Industry median 7.52% (219 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 5)
  • Yes Debt to equity is below 0.5 (0.25)
  • No Return on equity is 15% or more (14.9%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Buy Zone)
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.6%
Low 1011.0000 · High 1030.0000
1W return
-7.4%
Low 1011.0000 · High 1099.0000
1M return
-15.9%
Low 1011.0000 · High 1254.8000
52W return
-41.5%
Low 807.0000 · High 1771.0000
Lifetime High ₹2344.3500 (Oct. 15, 2024)
Lifetime Low ₹406.4500 (Aug. 18, 2021)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
1038.0
10D
1064.8
20D
1096.9
50D
1119.4
100D
1119.8
200D
1110.6

Delivery and volume

Day avg. delivery
66.0%
Week avg. delivery
57.7%
Month avg. delivery
53.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1017.83
Pivot
First resistance1024.67
Second resistance1036.83
Third resistance1043.67
First support1005.67
Second support998.83
Third support986.67
Day RSI28.9
Day MFI17.6
Day MACD-33.10
Day MACD signal-19.45

Beta

1M1.25
3M0.81
1Y1.40
3Y1.23

Price change analysis

↓ -15.9%
Over 1 Month
LowHigh
1011.001254.80
↓ -4.8%
Over 3 Months
LowHigh
969.001264.80
↑ 16.5%
Over 6 Months
LowHigh
834.101400.00
↓ -41.5%
Over 1 Year
LowHigh
807.001771.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 16.1 (own history: 10.5–32.5)
Buy Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹705 Cr
Net profit (June 30, 2026)
₹99 Cr
Basic EPS (June 30, 2026)
₹22.9900

Ranks #42 of 221 in Chemicals & Petrochemicals by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter68.83%
  • Mutual funds5.52%
  • FII/FPI1.03%
  • Other DII0.04%
  • Public24.58%

Largest holders

NameCategoryShares %Shares
Ashishbhai Natawarlal SoparkarPromoter14.6500%6319857
Patel Natwarlal MeghjibhaiPromoter9.6800%4176851
Jayantibhai Meghjibhai PatelPromoter8.2900%3576707
Rameshbhai Meghjibhai PatelPromoter6.7900%2929569
Maulik Jayantibhai PatelPromoter5.1900%2239091

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 68.83% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 1.54% to 1.03% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 4.90% to 5.52% in Jun 2026 qtr

6 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 45 insider trades, 0 SAST, 0 pledge events →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
5 Jun 2023 RAMESHBHAI MEGHJIBHAI PATEL Promoter Buy 0 ₹0
1 Jun 2023 RAMESHBHAI MEGHJIBHAI PATEL Promoter Buy 0 ₹0
20 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
17 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
16 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
15 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
7 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
1 Mar 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
28 Feb 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0
22 Feb 2023 MAULIK JAYANTIBHAI PATEL Promoter Buy 0 ₹0

All insider and SAST disclosures →

Dividends

Full dividend history →
Last 12 months ₹5.00 per share
Dividend yield 0.49%
Ex-dateSubjectPer share (₹)Record date
1 Jun 2026 Dividend - Rs 5 Per Share 5.0000 1 Jun 2026
20 Jun 2025 Dividend - Rs 3.50 Per Share 3.5000 21 Jun 2025
7 Feb 2025 Interim Dividend - Rs 2.50 Per Share 2.5000 7 Feb 2025
2 Jul 2024 Annual General Meeting/Dividend - Rs 5 Per Share 5.0000 2 Jul 2024
20 Jun 2023 Dividend - Rs 2.50 Per Share 2.5000 20 Jun 2023
1 Feb 2023 Interim Dividend - Rs 2.50 Per Share 2.5000 1 Feb 2023

Corporate Actions

Full history (10 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Meghmani Finechem Limited to Epigral Limited
20 Jun 2023OTHERAnnual General Meeting
17 Jun 2022OTHERAnnual General Meeting
15 Sep 2021OTHER Annual General Meeting

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
27 Jul 2026 Financial Results Yes
2 May 2026 Financial Results/Dividend Yes
30 Jan 2026 Financial Results Yes
10 Nov 2025 Financial Results Yes
2 Aug 2025 Financial Results/Fund Raising Yes

Corporate Announcements

All 546 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
28 Sep 2026 Trading Window Epigral Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
28 Sep 2026 Insider Trading / SAST Epigral Ltd - 543332 - Closure of Trading Window
16 Sep 2026 Company Update Epigral Ltd - 543332 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
16 Sep 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about the officials of the Company are participating in Anand Rathi Annual Flagship Conference: G-200 Summit 2026 scheduled on 21.09.2026.
31 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about Investor / Analyst Plant Visit on Thursday, 03.09.2026
18 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on thursday, 20.08.2026
7 Aug 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about participation in EMKAY Confluence 2026 on 12th August, 2026
30 Jul 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about One-on-One Meeting with Investor / Analyst on Monday, 3rd August, 2026.
30 Jul 2026 Analysts/Institutional Investor Meet/Con. Call Updates Epigral Limited has informed the Exchange about Transcript
29 Jul 2026 Copy of Newspaper Publication Epigral Limited has informed the Exchange about Copy of Newspaper Publication - Un-Audited Financial Results for the First Quarter ended 30.06.2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.25)
  • Strong revenue growth YoY (16.3%)

Weaknesses

  • Declining profit YoY (-5.4%)

Opportunities

  • RSI in oversold territory (28.9) -- a technical rebound zone

Threats

  • Down 41.5% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Epigral Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.